Carrick Newsroom

Special Advisor Dr. Frist Draws Acclaim From Alma Mater

administration-america-american-flag-932352.jpg

The Stanford Medical Center Alumni Association posted an article about Dr Frist’s role with Carrick Capital Partners in their "Class Notes" section.

“William H. Frist (Resident ’85, Fellow ’85-’87) Carrick Capital Partners, LLC, an investment firm focused on fast growing software and technology-enabled services firms, announced that Senator William H. Frist, MD, Resident ’85, Med Fellow ’87, has become a Special Advisor to the firm.

Dr. Frist is a nationally acclaimed heart and lung transplant surgeon, former U. S. Senate Majority Leader, and chairman of the Executive Board of the health service private equity firm Cressey & Company.

He represented Tennessee in the U.S. Senate for 12 years where he served on both the Health and Finance committees responsible for writing health legislation. He was elected Majority Leader of the Senate, having served fewer total years in Congress than any person chosen to lead that body in history.

His leadership was instrumental in passage of the 2003 Medicare Modernization Act to provide prescription drugs at lower costs to seniors and the historic legislation (PEPFAR) that reversed the spread of HIV/AIDS worldwide.”

About Carrick Capital Partners
Who We Are
A firm of enterprise software and technology enabled services investors and operating executives with substantial experience founding, scaling, and optimizing market leading businesses.
Our Approach
We work with management to identify and improve critical areas of their business - focusing on the priorities that align with our experiences and that will deliver the highest strategic impact in both the short-term and long-run.
Why We Are Different
We have a concentrated number of companies in our portfolio so that we can build substantial relationships with each management team and ensure our firm's commitment to each company's goals.
Latest News
InfiniaML Logo.jpg
Infinia ML Chief Scientist Larry Carin Raises NeurIPS/NIPS Research Contributions to 44 Papers Since 2004
December 4, 2018
Exiger Logo.jpg
New York, NY (November 27, 2018) - Exiger, the leader in the provision of technology-enabled regulatory, financial crime, risk, and compliance solutions, is pleased to announce that Jill Denham has been appointed to its Board of Directors. Ms. Denham is a renowned senior executive and corporate director in financial services and other industries.
November 27, 2018
Accolade Logo.jpg
SEATTLE, Nov. 20, 2018 /PRNewswire/ -- Innovative health and benefits strategies can fundamentally improve the healthcare experience, outcomes and cost structure for more than 180 million people receiving employer-sponsored health insurance in the U.S., according to Personalized Advocacy provider Accolade. The company's CEO Rajeev Singhwill share these strategies and independently validated outcomes research at the upcoming Piper Jaffray Annual Healthcare Conference in New York City November 28th.
November 20, 2018